Acute Precipitants of Congestive Heart Failure Exacerbations
Author(s) -
Ross T. Tsuyuki,
Robert S. McKelvie,
J. Malcolm O. Arnold,
Álvaro Avezum,
Antônio Carlos Pereira Barretto,
Antônio Carlos Carvalho,
Debra Isaac,
Allan D. Kitching,
Leopoldo Soares Piegas,
K. K. Teo,
Salim Yusuf
Publication year - 2001
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.161.19.2337
Subject(s) - medicine , exacerbation , heart failure , enalapril , ejection fraction , cardiology , randomized controlled trial , randomization , placebo , intensive care medicine , angiotensin converting enzyme , blood pressure , alternative medicine , pathology
Few studies have prospectively and systematically explored the factors that acutely precipitate exacerbation of congestive heart failure (CHF) in patients with left ventricular dysfunction. Knowledge of such factors is important in designing measures to prevent deterioration of clinical status. The objective of this study was to prospectively describe the precipitants associated with exacerbation of CHF status in patients enrolled in the Randomized Evaluation of Strategies for Left Ventricular Dysfunction Pilot Study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom